I attended a meeting at the request of representatives from the Irish Pharmaceutical Healthcare Association (IPHA) and Biopharmachem Ireland (BPCI) on 25th June 2021. This meeting was attended by Paul Reid, who is the President of IPHA and Managing Director of Pfizer Healthcare Ireland. The purpose of the meeting was to discuss a range of topics, which included the then WTO TRIPS waiver proposal.
A draft Ministerial Decision on the TRIPS waiver is one of the proposals under consideration at the WTO Ministerial Conference currently taking place in Geneva from 12th and 15th June with the aim of finding a solution that will be acceptable to all WTO Members. The draft Decision offers the most promising path towards achieving a meaningful outcome that will contribute to ensuring access to safe and effective vaccines across the globe.